Company / CapEx per Share
Vanda Pharmaceuticals Inc. CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.01
FY2025
5-year range
$0.01 / $0.03
FY2021-FY2025
Trend
-44.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share has fluctuated over the past 10 years, ranging from $0.01 in FY2025 to $0.06 in FY2017.
Based on SEC 10-K filings.
0.01 in FY2025 with a 5-year CAGR of -0.9%.
Declined from $0.01 to $0.01 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -41.1%
- 5-Year CAGR
- -0.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, capex per share decreased 44.3% year-over-year.
- Peak capex per share was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score -3.96 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | -44.3% |
| FY2024 | $0.01 | +21.4% |
| FY2023 | $0.01 | -69.7% |
| FY2022 | $0.03 | +72.9% |
| FY2021 | $0.02 | +170.3% |
| FY2020 | $0.01 | -78.3% |
| FY2019 | $0.03 | +1.3% |
| FY2018 | $0.03 | -45.5% |
| FY2017 | $0.06 | +219.8% |
| FY2016 | $0.02 | +323.4% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026